世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039126

ドイツの感染症分子診断市場(2024年):100種類の検査 - サプライヤーシェア、競争戦略、革新的技術、機器レビュー

VPGMarketResearch

2024 Germany Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

発刊日 2024/07/01

言語英語

体裁PDF

ライセンス/価格

0000039126

Local PDF
Global PDF
DataPack

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートはセクション別、市場セグメント別、個々の検査別に提供されており、特定の情報ニーズや予算に合わせてカスタマイズできます。

この新しい調査は、現在のサプライヤーと潜在的な市場参入者が、今後 5 年間の感染症分子診断市場における新たな機会を特定し、評価するのに役立つように設されています。

レポートのハイライト

  • 主要市場におけるビジネスおよび技術のトレンド
  • 5年間の検査量と売上予測
  • 主要競合他社の市場シェア
  • 主要分析装置の機能比較
  • 革新的な製品を開発している主要市場プレーヤーと新興企業の戦略プロファイル
  • 機器および消耗品サプライヤー向けの特定の製品とビジネスチャンス

論理的根拠

感染症分子診断市場は、体外診断業界で最も急速に成長している分野の1つです。今後5年間で、試薬システムと自動化の大きな進歩、そして革新的なマーケティングアプローチを必要とする幅広い新製品の導入が見られるでしょう。しかし、日常的な臨床検査室への市場浸透率は、増幅法を備えた費用対効果の高い自動化システムの導入にかかっています。

感染症分子診断市場がもたらす機会をうまく活用するために、多くの企業がすでに新しい分子技術を企業戦略資産として活用し、ビジネスおよびマーケティング戦略をサポートする形で管理しています。新しい技術計画をビジネスおよび企業戦略と統合することは、今後 5 年間で診断企業にとって最も困難な課題の 1 つとなるでしょう。

ドイツ市場の概要

  • 国別および市場セグメント別の感染症に対するDNAシーケンスおよび分子診断検査を実施するラボ
  • 国別の5年間の検査量および売上高予測

市場セグメンテーション分析

  • 感染症分子診断試薬キットおよびコンポーネントの主要サプライヤーの売上高と市場シェア
  • 40以上の感染症分子診断アッセイの5年間の検査量と売上予測
  • 国別およびラボセグメント別のシーケンシング市場の包括的な分析
  • 国別の市場ダイナミクス、トレンド、構造、規模、成長、主要サプライヤーのレビューを含む詳細な市場セグメンテーション分析

製品/技術レビュー

  • 主要な感染症分子診断分析装置の比較
  • 分子診断技術、検査形式、検出方法、検査自動化の動向、過剰標的/シグナル増幅法に関する広範なレビュー
  • 新しい分子診断技術や製品を開発している世界中の企業、大学、研究所のリスト

競争力評価

  • 以下の主要サプライヤーおよび新興市場参入企業の売上、製品ポートフォリオ、マーケティング戦略、協力体制、研究開発における新技術/製品などに関する広範な戦略的評価
    ➣ Abbott
    ➣ Agilent Technologies
    ➣ Applied Gene Technologies
    ➣ Arca Biopharma
    ➣ Beckman Coulter/Danaher/Cepheid
    ➣ Becton Dickinson
    ➣ Biokit
    ➣ bioMerieux
    ➣ Bio-Rad
    ➣ Decode Genetics
    ➣ Diasorin
    ➣ 栄研化学(Eiken Chemical)
    ➣ Elitech Group
    ➣ Enzo Biochem
    ➣ Exact Sciences
    ➣ 富士レビオ(Fujirebio)
    ➣ Grifols
    ➣ Hologic/Gen-Probe
    ➣ Illumina
    ➣ LabCorp/Sequenom
    ➣ Leica Biosystems/Kreatech
    ➣ Li-Cor Biosciences
    ➣ Myriad Genetics
    ➣ Proteome Sciences
    ➣ Qiagen
    ➣ Quest Diagnostics
    ➣ QuidelOrtho
    ➣ Roche
    ➣ 島津製作所(Shimadzu)
    ➣ Siemens Healthineers
    ➣ タカラバイオ(Takara Bio)
    ➣ Tecan Group
    ➣ Thermo Fisher
  • 感染症分子診断製品を開発・販売している企業の包括的なリスト(検査別・用途別)

機会と戦略的推奨事項

  • 今後 5 年間で市場への大きな訴求力を持つ可能性のある具体的な新製品開発の機会
  • 新製品の設計基準
  • 代替市場浸透戦略
  • 潜在的な市場参入障壁とリスク
  • 事業計画の問題と懸念事項

レポート詳細

目次

Table of Contents
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
O P-32
O S-35
O H-3
O I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
O Indirect Chemical Labeling
O Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan 48
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler 480
22. Roche Cobas 4800
23. Roche Cobas s 201
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications, Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
° Adenovirus
° Aeromonas
° Anthrax/Bacillus Anthracis
° Arboviruses
° Babesiosis
° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
° Blastocystis Hominis
° Brucella
° Campylobacter
° Candida
° Chagas Disease
° Chancroid
° Chlamydia
° Clostridium Difficile
° Coronaviruses
° Coxsackieviruses
° Creutzfeldt-Jakob’s Disease
° Cryptosporidium Parvum
° Cyclospora Cayetanensis
° Cytomegalovirus
° Ebola Virus
° E. Coli
° EchoVirus
° Encephalitis
° Enteroviruses
° Epstein-Barr Virus
° Giardia Lamblia
° Gonorrhea
° Granuloma Inguinale
° Hantavirus
° Helicobacter Pylori
° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
° Herpes Simplex Virus
° Human Herpes Virus-6 (HHV-6)
° Influenza Viruses
° Legionella
° Lyme Disease
° Lymphogranuloma Venereum (LGV)
° Malaria
° Measles (Rubeola)
° Meningitis
° Microsporidium
° Mononucleosis
° Mumps
° Mycoplasma
° Papillomaviruses
° Parvovirus B19
° Pneumonia
° Polyomaviruses
° Pseudomonas Aeruginosa
° Rabies
° Respiratory Syncytial Virus (RSV)
° Rhinoviruses
° Rotavirus
° Rubella
° Salmonellosis
° Septicemia
° Shigellosis
° Staphylococcus Aureus
° Streptococci
° Syphilis
° Toxoplasmosis
° Trichomonas Vaginalis
° Tuberculosis
° Vibrio
° West Nile Virus
° Yersina
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. Germany Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
XIII. Appendix: Major Universities and Research Centers
Developing Molecular Diagnostic Technologies

List of Tables
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Germany
Molecular Diagnostics Test Volume And Sales
By Major Application
Germany
Laboratories Performing DNA Sequencing
By Market Segment
Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Germany
Molecular Diagnostics Test Volume
By Major Application
Germany
Major Infectious Disease Test Volume by Assay
Germany
Major Infectious Disease Test Volume by Method
Germany
Molecular Diagnostics Market
By Major Application
Germany
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
Germany
Major Infectious Disease Diagnostics Market by Assay
Germany
AIDS Testing Market
Estimated Sales by Major Supplier
Germany
CMV Testing Market
Estimated Sales by Major Supplier
Germany
EBV Testing Market
Estimated Sales by Major Supplier
Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier
Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier
Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
Germany
Herpes Testing Market
Estimated Sales by Major Supplier
Germany
Influenza Testing Market
Estimated Sales by Major Supplier
Germany
Meningitis Testing Market
Estimated Sales by Major Supplier
Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier
Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier
Germany
RSV Testing Market
Estimated Sales by Major Supplier
Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier

この商品のレポートナンバー

0000039126

TOP